Heltra: Explore Life – Discover More – Live Better

Eli Lilly bets $409M for AI-focused drug discovery (NYSE:LLY)

Eli Lilly Italy. 140th Anniversary party.

lcodacci

Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to develop gene-based therapeutics.

As a part of the deal, the duo will leverage Genetic Leap’s RNA-targeted AI platform toLLY

Source: Seekingalpha

ADVERTISEMENT